By specifically targeting exon regions, whole-exome sequencing (WES) is an affordable and efficient approach for translational cancer research, allowing the detection of rare gene variations and helping to discover new cancer biomarkers.
In addition, WES aids in the discovery of novel gene disease and genotype-phenotype associations and helps to uncover the genetic cause of multiple diagnoses in a single patient by addressing phenotypic variability.
Offered Free by: Qiagen
See All Resources from: Qiagen
This download should complete shortly. If the resource doesn't automatically download, please, click here.